ScholarIQanswers from OpenAlex & ORCID
Steven M. Devine
ResearcherPublications, citations & collaboration network
Steven M. Devine is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Steven M. Devine have?
ScholarIQindexed works
Steven M. Devine has 650 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Steven M. Devine have?
ScholarIQcitation count
Steven M. Devine has 27,451 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Steven M. Devine?
ScholarIQh-index
Steven M. Devine has an h-index of 78 in OpenAlex.
What is the i10-index of Steven M. Devine?
ScholarIQi10-index
Steven M. Devine has an i10-index of 251 in OpenAlex.
What is the ORCID of Steven M. Devine?
ScholarIQorcid
The ORCID for Steven M. Devine is on the source record.
What is the OpenAlex record for Steven M. Devine?
ScholarIQopenalex
The OpenAlex for Steven M. Devine is on the source record.
What are the most-cited papers on Steven M. Devine?
ScholarIQmost cited works
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D’Souza, Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra, Steven M. Devine, Mary Eapen, Mehdi Hamadani, Parameswaran Hari, Marcelo C. Pasquini, Waleska S. Pérez, Rachel Phelan, Marcie Riches, J. Douglas Rizzo, Wael Saber, Bronwen E. Shaw, Stephen R. Spellman, Patricia Steinert, Daniel J. Weisdorf, Mary M. Horowitz
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine
William Blum, Ramiro Garzon, Rebecca B. Klisovic, Sebastian Schwind, Alison Walker, Susan M. Geyer, Shujun Liu, Violaine Havelange, Heiko Becker, Larry J. Schaaf, Jon Mickle, Hollie Devine, Cheryl Kefauver, Steven M. Devine, Kenneth K. Chan, Nyla A. Heerema, Clara D. Bloomfield, Michael R. Grever, John C. Byrd, Miguel A. Villalona‐Calero, Carlo M. Croce, Guido Marcucci
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand, Arnon Nagler, Edie Weller, Steven M. Devine, David Avigan, Yi‐Bin Chen, Mark Kaminski, H. Kent Holland, Jane N. Winter, James R. Mason, Joseph W. Fay, David A. Rizzieri, Chitra Hosing, Edward D. Ball, Joseph P. Uberti, Hillard M. Lazarus, Markus Y. Mapara, Stephanie A. Gregory, John M. Timmerman, David Andorsky, Reuven Or, Edmund K. Waller, Rinat Rotem‐Yehudar, Leo I. Gordon
Outcome of Transplantation for Myelofibrosis
Karen K. Ballen, Smriti Shrestha, Kathleen A. Sobocinski, Mei-Jie Zhang, Asad Bashey, Brian J. Bolwell, Francisco Cervantes, Steven M. Devine, Robert Peter Gale, Vikas Gupta, Theresa Hahn, William J. Hogan, Nicolaus Kröger, Mark R. Litzow, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Gary J. Schiller, Harry C. Schouten, Vivek Roy, Peter H. Wiernik, Mary M. Horowitz, Sergio Giralt, Mukta Arora
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven M. Devine, Yvonne A. Efebera, S. Ganguly, Cristina Gasparetto, Nancy L. Geller, Mary M. Horowitz, John Koreth, Kristin Knust, Heather Landau, Claudio G. Brunstein, Philip L. McCarthy, Courtney Nelson, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Ravi Vij, Dan T. Vogl, Sergio Giralt, George Somlo, Amrita Krishnan